Matthew Jarpe,
Associate Vice President Of Biology
Matthew Jarpe is an Associate Director of Biology at Acetylon Pharmaceuticals in Boston, Massachusetts. He received his PhD from Johns Hopkins and completed his postdoctoral training at National Jewish Medical Center. Prior to joining Acetylon he worked at Biogen and Surface Logix. At Acetylon he has helped develop highly selective inhibitors for HDAC6 as well as HDAC1 and 2. His work has focused on the non-oncology uses of HDAC inhibitors, primarily in neurologic indications.
|
|
|
